- Global Pharma News & Resources

Press Releases - 2023-03-27

Date Title Company
27-Mar-2023 Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A.; Joachim Kreuzburg remains Chairman of the Board Sartorius Stedim Biotech SA
27-Mar-2023 Helping lubricants and grease producers navigate new regulations SciMed
27-Mar-2023 Secarna Pharmaceuticals and SciNeuro Pharmaceuticals enter into research and option agreement in the field of CNS diseases Secarna Pharmaceuticals GmbH & Co. KG
27-Mar-2023 Uni-Bio Science Group Limited: 2022 Annual Results UNI-BIO SCIENCE GROUP LIMITED
27-Mar-2023 The 33rd Edition of the FIME Show is Coming Live in June 2023 Siora Surgical Pvt. Ltd
27-Mar-2023 PharmaBlock Opens New R&D Facility in Pennsylvania -- Expanding Capacity to Deliver GMP Projects PharmaBlock
27-Mar-2023 Helix VaxApp gets approval from NHS England to boost vaccine management Telstra Health UK
27-Mar-2023 Vitruvia Medical AG: auhtorised capital increase Vitruvia Medical AG
27-Mar-2023 U.S. Burn AI Clinical Training Study Enrollment Completed STIFEL
27-Mar-2023 U.S. Burn AI Clinical Training Study Enrollment Completed” WH Ireland Capital Markets
27-Mar-2023 Calibre Scientific Acquires SciQuip, a UK Provider of Scientific Equipment, Supplies and Services Calibre
27-Mar-2023 The Impact of Menopause on Joint Health Cytoplan
27-Mar-2023 Game on as New Training Method Saves Liverpool NHS 40,000 Hours ATTENSI
27-Mar-2023 U.S. Burn AI Clinical Training Study Enrollment Completed Spectral MD Holdings, Ltd
27-Mar-2023 Theriva Biologics to Reschedule Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2022 Operational Highlights and Financial Results Theriva
27-Mar-2023 Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments Vaccitech
27-Mar-2023 HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration HpVac
27-Mar-2023 Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme Apogenix AG
27-Mar-2023 Grünenthal GmbH: Grünenthal reports record revenue and profit in 2022 full-year results and strong pipeline progress (news with additional features) Grünenthal GmbH
27-Mar-2023 Biophytis: Biophytis presented Sarconeos (BIO101) as a possible treatment candidate for long COVID after hospitalization during the 13th annual International Conference on Frailty and Sarcopenia Resea Biophytis